Trevor J. Pugh

43.4k total citations · 1 hit paper
149 papers, 5.0k citations indexed

About

Trevor J. Pugh is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Trevor J. Pugh has authored 149 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Cancer Research, 56 papers in Oncology and 52 papers in Molecular Biology. Recurrent topics in Trevor J. Pugh's work include Cancer Genomics and Diagnostics (65 papers), Cancer Immunotherapy and Biomarkers (19 papers) and Multiple Myeloma Research and Treatments (14 papers). Trevor J. Pugh is often cited by papers focused on Cancer Genomics and Diagnostics (65 papers), Cancer Immunotherapy and Biomarkers (19 papers) and Multiple Myeloma Research and Treatments (14 papers). Trevor J. Pugh collaborates with scholars based in Canada, United States and United Kingdom. Trevor J. Pugh's co-authors include Arnavaz Danesh, Daniel D. De Carvalho, Catherine O′Brien, Yadong Wang, Gangning Liang, Han Han, Shu Yi Shen, Helen Loo Yau, Rajat Singhania and Peter A. Jones and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Trevor J. Pugh

134 papers receiving 4.9k citations

Hit Papers

DNA-Demethylating Agents Target Colorectal Cancer Cells b... 2015 2026 2018 2022 2015 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Trevor J. Pugh Canada 34 2.8k 1.4k 1.3k 857 700 149 5.0k
Elizabeth A. Harrington United States 26 3.2k 1.2× 1.9k 1.4× 710 0.6× 517 0.6× 714 1.0× 69 5.1k
Jamie K. Teer United States 32 2.1k 0.8× 1.7k 1.2× 1.1k 0.8× 993 1.2× 631 0.9× 96 4.4k
Malachi Griffith United States 35 4.0k 1.5× 1.4k 1.0× 2.2k 1.7× 1.2k 1.3× 744 1.1× 100 6.5k
Charles Y. Lin United States 26 7.3k 2.6× 1.2k 0.9× 1.1k 0.9× 857 1.0× 364 0.5× 64 8.7k
Carla Boccaccio Italy 33 2.1k 0.8× 1.4k 1.1× 809 0.6× 501 0.6× 518 0.7× 63 4.2k
Aykut Üren United States 39 3.7k 1.3× 908 0.7× 554 0.4× 374 0.4× 1.0k 1.5× 126 5.1k
Michael Jeffers United States 36 3.4k 1.2× 1.6k 1.2× 997 0.8× 437 0.5× 770 1.1× 78 5.7k
Michael Datto United States 34 4.1k 1.5× 2.2k 1.6× 1.4k 1.1× 367 0.4× 844 1.2× 69 6.4k
Paul Haluska United States 38 2.5k 0.9× 2.0k 1.5× 1.1k 0.9× 497 0.6× 618 0.9× 114 4.9k
Joost van den Oord Belgium 28 2.9k 1.1× 1.4k 1.0× 957 0.7× 1.6k 1.9× 499 0.7× 79 5.5k

Countries citing papers authored by Trevor J. Pugh

Since Specialization
Citations

This map shows the geographic impact of Trevor J. Pugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trevor J. Pugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trevor J. Pugh more than expected).

Fields of papers citing papers by Trevor J. Pugh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trevor J. Pugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trevor J. Pugh. The network helps show where Trevor J. Pugh may publish in the future.

Co-authorship network of co-authors of Trevor J. Pugh

This figure shows the co-authorship network connecting the top 25 collaborators of Trevor J. Pugh. A scholar is included among the top collaborators of Trevor J. Pugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trevor J. Pugh. Trevor J. Pugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campos, Cecília Bonolo de, Zhihua Li, Daniel K.C. Lee, et al.. (2025). PIKfyve inhibition in MM disrupts autophagy and lysosome function, increasing MHC expression and cholesterol metabolism. Blood. 147(6). 650–661. 1 indexed citations
2.
Campos, Cecília Bonolo de, Zhihua Li, Michael St. Paul, et al.. (2025). Autophagy/lysosome disruption via pikfyve inhibition in multiple myeloma. Blood. 146(Supplement 1). 3316–3316.
3.
Pintilie, Melania, Kathy Han, Anthony Fyles, et al.. (2024). An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical Cancer. Clinical Cancer Research. 30(6). 1200–1207. 4 indexed citations
4.
Rose, April A. N., Ian King, Tong Zhang, et al.. (2024). Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Final results of the investigator-initiated phase II BEAVER trial.. Journal of Clinical Oncology. 42(16_suppl). 3104–3104. 2 indexed citations
5.
Lheureux, Stéphanie, Taymaa May, Michelle Wilson, et al.. (2024). Phase II randomized multi-centre study of neoadjuvant olaparib in patients with platinum sensitive relapsed high grade serous ovarian cancer: The NEO trial.. Journal of Clinical Oncology. 42(16_suppl). 5506–5506. 1 indexed citations
6.
Kondratyev, Maria, Troy Ketela, Natalie Stickle, et al.. (2023). Identification of acquired Notch3 dependency in metastatic Head and Neck Cancer. Communications Biology. 6(1). 538–538. 7 indexed citations
7.
Prokopec, Stephenie D., Yvonne Bombard, Trevor J. Pugh, et al.. (2023). Abstract 6545: Investigating secondary findings in a pediatric cancer cohort: preliminary findings. Cancer Research. 83(7_Supplement). 6545–6545.
8.
Wong, Derek, Ping Luo, Arnavaz Danesh, et al.. (2023). Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma. Cancer Research Communications. 3(2). 267–280. 9 indexed citations
9.
Shi, Wei, Jeffrey P. Bruce, Jie Su, et al.. (2022). CD8+ Tumor-Infiltrating Lymphocyte Abundance Is a Positive Prognostic Indicator in Nasopharyngeal Cancer. Clinical Cancer Research. 28(23). 5202–5210. 7 indexed citations
10.
Pugh, Trevor J., Jeffrey P. Bruce, Gary J. Doherty, et al.. (2022). AACR Project GENIE: 100,000 Cases and Beyond. Cancer Discovery. 12(9). 2044–2057. 49 indexed citations
11.
Komosa, Martin, Sumedha Sudhaman, Ricardo Leão, et al.. (2021). Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer. Journal of Clinical Investigation. 131(21). 1570–1575. 18 indexed citations
12.
Lheureux, Stéphanie, Ana Oaknin, Swati Garg, et al.. (2020). EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression. Clinical Cancer Research. 26(16). 4206–4215. 95 indexed citations
13.
Díaz-Mejía, J. Javier, Ping Luo, Samarth Patel, et al.. (2020). CReSCENT: CanceR Single Cell ExpressioN Toolkit. Nucleic Acids Research. 48(W1). W372–W379. 10 indexed citations
14.
Restall, Ian J., et al.. (2020). Brain Tumor Stem Cell Dependence on Glutaminase Reveals a Metabolic Vulnerability through the Amino Acid Deprivation Response Pathway. Cancer Research. 80(24). 5478–5490. 29 indexed citations
15.
Longo, Joseph, Petr Smirnov, Zhihua Li, et al.. (2020). The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma. Leukemia. 35(3). 796–808. 25 indexed citations
16.
Toker, Aras, Linh T. Nguyen, Simone C. Stone, et al.. (2018). Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma. Clinical Cancer Research. 24(22). 5685–5696. 85 indexed citations
17.
Giannikou, Krinio, Izabela A. Malinowska, Trevor J. Pugh, et al.. (2016). Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development. PLoS Genetics. 12(8). e1006242–e1006242. 85 indexed citations
18.
Mandelker, Diana, Sami S. Amr, Trevor J. Pugh, et al.. (2014). Comprehensive Diagnostic Testing for Stereocilin. Journal of Molecular Diagnostics. 16(6). 639–647. 46 indexed citations
19.
Liao, Rachel G., Joonil Jung, Jeremy H. Tchaicha, et al.. (2013). Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma. Cancer Research. 73(16). 5195–5205. 134 indexed citations
20.
Pugh, Trevor J., Mira Keyes, Lorena Barclay, et al.. (2009). Sequence Variant Discovery in DNA Repair Genes from Radiosensitive and Radiotolerant Prostate Brachytherapy Patients. Clinical Cancer Research. 15(15). 5008–5016. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026